dimaprit has been researched along with Breast Cancer in 1 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, AK | 1 |
| Zamre, V | 1 |
| Chaudhary, P | 1 |
| Sharma, G | 1 |
| Singh, D | 1 |
1 other study available for dimaprit and Breast Cancer
| Article | Year |
|---|---|
APT Trial: Would It Really Help in De-Escalation of Therapy?
Topics: Breast Neoplasms; Dimaprit; Follow-Up Studies; Humans; Paclitaxel; Receptor, ErbB-2; Trastuzumab | 2019 |